Discordance between peritumoral and subareolar injections for mapping sentinel lymph nodes in the breast.

Breast cancer Peritumoral Sentinel lymph node Subareolar

Journal

Breast cancer research and treatment
ISSN: 1573-7217
Titre abrégé: Breast Cancer Res Treat
Pays: Netherlands
ID NLM: 8111104

Informations de publication

Date de publication:
15 Sep 2024
Historique:
received: 19 07 2024
accepted: 02 09 2024
medline: 15 9 2024
pubmed: 15 9 2024
entrez: 14 9 2024
Statut: aheadofprint

Résumé

Sentinel node biopsy (SNB) is a common staging tool for breast cancer. Initially, peritumoral (PT) injections were used, however subareolar (SA) injections were later introduced to simplify the technique. Controversy remains regarding whether PT and SA injections map the same sentinel lymph nodes (SLNs). This study aimed to determine whether the regional location of breast SLNs differs when using PT versus SA injections using a large dataset from a single institution. A total of 1035 patients who underwent breast SNB (PT injections: n = 858 and SA injections: n = 177) with lymphoscintigraphy and SPECT/CT were included. The identified SLN locations using SA injections were compared with those using PT injections. Differences in drainage proportions and odds ratios (ORs) for each clockface breast region and the whole breast were calculated using a two-proportion z-test and Fisher's Exact Test. A higher proportion of internal mammary SLNs were identified using PT injections for the whole breast (0.30 versus 0.09) and for all breast regions, with all regions showing statistical significance except the upper outer quadrant. Similarly, ORs showed identification of internal mammary SLNs was significantly higher when using PT injections (4.35, 95% CI 2.53 to 7.95). There were no significant differences in identifying axillary SLNs between injection sites. This is the largest cohort study to compare the regional location of breast SLNs identified using PT injections versus SA injections. Discordance was shown in the SLNs identified between injection techniques, with PT injections more frequently identifying internal mammary SLNs.

Identifiants

pubmed: 39277550
doi: 10.1007/s10549-024-07491-8
pii: 10.1007/s10549-024-07491-8
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Health Research Council of New Zealand
ID : 20/017

Informations de copyright

© 2024. The Author(s).

Références

Pereira Arias-Bouda LM, Vidal-Sicart S, Valdés Olmos RA (2020) Preoperative and intraoperative lymphatic mapping for radioguided sentinel lymph node biopsy in breast cancer. In: Mariani G, Vidal-Sicart S, Valdés Olmos RA (eds) Atlas of lymphoscintigraphy and sentinel node mapping a pictorial case-based approach. springer, Cham, pp 185–217. https://doi.org/10.1007/978-3-030-45296-4_9
doi: 10.1007/978-3-030-45296-4_9
Ahmed M, Purushotham AD, Horgan K, Klaase JM, Douek M (2015) Meta-analysis of superficial versus deep injection of radioactive tracer and blue dye for lymphatic mapping and detection of sentinel lymph nodes in breast cancer’. Br J Surg. https://doi.org/10.1002/bjs.9673
doi: 10.1002/bjs.9673 pubmed: 26663252
Valdés Olmos RA, Vidal-Sicart S (2023) Nuclear medicine contribution to precision surgery in breast cancer. Revista Española de Medicina Nuclear e Imagen Molecular 42(5):343–351. https://doi.org/10.1016/j.remnie.2023.07.001
doi: 10.1016/j.remnie.2023.07.001 pubmed: 37422262
Sappey MPC (1874) Anatomie, physiologie, pathologie des vaisseaux lymphatiques considérés chez l’homme et les vertébrés. Adrien Delahaye, Paris
Suami H, Pan WR, Mann GB, Taylor GI (2008) The lymphatic anatomy of the breast and its implications for sentinel lymph node biopsy: a human cadaver study. Ann Surg Oncol 15(3):863–871. https://doi.org/10.1245/s10434-007-9709-9
doi: 10.1245/s10434-007-9709-9 pubmed: 18043970
Uren RF et al (2012) SPECT/CT scans allow precise anatomical location of sentinel lymph nodes in breast cancer and redefine lymphatic drainage from the breast to the axilla. Breast 21(4):480–486. https://doi.org/10.1016/j.breast.2011.11.007
doi: 10.1016/j.breast.2011.11.007 pubmed: 22153573
Blumgart EI, Uren RF, Nielsen PMF, Nash MP, Reynolds HM (2011) Predicting lymphatic drainage patterns and primary tumour location in patients with breast cancer. Breast Cancer Res Treat 130(2):699–705. https://doi.org/10.1007/s10549-011-1737-2
doi: 10.1007/s10549-011-1737-2 pubmed: 21850393
Situ J et al (2024) An interactive 3D atlas of sentinel lymph nodes in breast cancer developed using SPECT/CT. Cancer Imaging. https://doi.org/10.1186/s40644-024-00738-z
doi: 10.1186/s40644-024-00738-z pubmed: 39080795 pmcid: 11289966
Sadeghi R, Asadi M, Treglia G, Zakavi SR, Fattahi A, Krag DN (2014) Axillary concordance between superficial and deep sentinel node mapping material injections in breast cancer patients: systematic review and meta-analysis of the literature. Breast Cancer Res Treat. https://doi.org/10.1007/s10549-014-2866-1
doi: 10.1007/s10549-014-2866-1 pubmed: 24878987
Spillane AJ, Noushi F, Cooper RA, Gebski V, Uren RF (2009) High-resolution lymphoscintigraphy is essential for recognition of the significance of internal mammary nodes in breast cancer. Ann Oncol. https://doi.org/10.1093/annonc/mdn725
doi: 10.1093/annonc/mdn725 pubmed: 19153113
Noushi F et al (2013) High discordance rates between sub-areolar and peri-tumoural breast lymphoscintigraphy. Eur J Surg Oncol 39(10):1053–1060. https://doi.org/10.1016/j.ejso.2013.06.006
doi: 10.1016/j.ejso.2013.06.006 pubmed: 23871572
Freebody JA, Fernando S, Rossleigh M (2019) Triple-site radiotracer application in breast lymphoscintigraphy and sentinel node discordance. World J Nucl Med 18(02):127–131. https://doi.org/10.4103/wjnm.wjnm_32_18
doi: 10.4103/wjnm.wjnm_32_18 pubmed: 31040742 pmcid: 6476254
Rubio IT et al (2015) The superparamagnetic iron oxide is equivalent to the Tc99 radiotracer method for identifying the sentinel lymph node in breast cancer. Eur J Surg Oncol 41(1):46–51. https://doi.org/10.1016/j.ejso.2014.11.006
doi: 10.1016/j.ejso.2014.11.006 pubmed: 25466980
Zetterlund L et al (2016) Impact of previous surgery on sentinel lymph node mapping: Hybrid SPECT/CT before and after a unilateral diagnostic breast excision. Breast 30:32–38. https://doi.org/10.1016/j.breast.2016.08.006
doi: 10.1016/j.breast.2016.08.006 pubmed: 27597384
Zhang JJ, Zhang WC, An CX, Li XM, Ma L (2019) Comparative research on 99mTc-Rituximab and 99mTc-sulfur colloid in sentinel lymph node imaging of breast cancer’. BMC Cancer. https://doi.org/10.1186/s12885-019-6197-9
doi: 10.1186/s12885-019-6197-9 pubmed: 31888612 pmcid: 6938003
McDonald JH (2014) Small numbers in chi-square and G–tests, In: Handbook of biological statistics, 3rd ed., Sparky House Publishing, Baltimore, pp 86–89. https://www.biostathandbook.com/HandbookBioStatThird.pdf
Armstrong RA (2014) When to use the bonferroni correction. Ophthalmic Physiol Optic. https://doi.org/10.1111/opo.12131
doi: 10.1111/opo.12131
R Core Team, (2024) R: a language and environment for statistical computing, 2021, R foundation for statistical computing, Vienna, Austria. https://www.r-project.org/ Accessed Jul 09 2024
Maza S et al (2003) Peritumoural versus subareolar administration of technetium-99m nanocolloid for sentinel lymph node detection in breast cancer: Preliminary results of a prospective intra-individual comparative study. Eur J Nucl Med Mol Imaging 30(5):651–656. https://doi.org/10.1007/s00259-003-1128-y
doi: 10.1007/s00259-003-1128-y pubmed: 12612811
Hashem T, Abdelmoez A, Rozeka AM, Abdelazeem H (2021) Intra-mammary lymph nodes, an overlooked breast cancer prognostic tool? World J Surg Oncol. https://doi.org/10.1186/s12957-021-02219-0
doi: 10.1186/s12957-021-02219-0 pubmed: 33849561 pmcid: 8045254
Delamere G, Poirier P, Cuneo B (1903) The lymphatics. In: Charpy P (ed) A treatise of human anatomy. Archibald Constable, Westminster
Manca G et al (2014) Sentinel lymph node mapping in breast cancer: a critical reappraisal of the internal mammary chain issue. Q J Nucl Med Mol Imaging 58(2):114–126
pubmed: 24835288
Teichgraeber DC, Guirguis MS, Whitman GJ (2021) Breast cancer staging: updates in the AJCC cancer staging manual 8th edition, and current challenges for radiologists, from the AJR special series on cancer staging. Am J Roentgenol. https://doi.org/10.2214/AJR.20.25223
doi: 10.2214/AJR.20.25223
Noushi F, Spillane AJ, Uren RF, Gebski V (2010) Internal mammary node metastasis in breast cancer: predictive models to determine status & management algorithms. Eur J Surg Oncol 36(1):16–22. https://doi.org/10.1016/j.ejso.2009.09.006
doi: 10.1016/j.ejso.2009.09.006 pubmed: 19846271
Lenihan J, Rangaswamy G, Faul C (2022) The role of radiotherapy in the management of nodal disease in breast cancer. Rep Pract Oncol Radiother 27(2):331–343. https://doi.org/10.5603/rPOr.a2022.0037
doi: 10.5603/rPOr.a2022.0037 pubmed: 36299373 pmcid: 9591026
Thorsen L et al (2022) DBCG radiotherapy committee. internal mammary node irradiation in patients with node-positive early breast cancer: fifteen-year results from the danish breast cancer group internal mammary node study. J Clin Oncol 40(36):4198–4206
doi: 10.1200/JCO.22.00044 pubmed: 35394824
Kawase K et al (2006) Use of lymphoscintigraphy defines lymphatic drainage patterns before sentinel lymph node biopsy for breast cancer. J Am Coll Surg 203(1):64–72. https://doi.org/10.1016/j.jamcollsurg.2006.03.015
doi: 10.1016/j.jamcollsurg.2006.03.015 pubmed: 16798488
Kong AL et al (2012) Impact of internal mammary lymph node drainage identified by preoperative lymphoscintigraphy on outcomes in patients with stage i to III breast cancer’. Cancer. https://doi.org/10.1002/cncr.27564
doi: 10.1002/cncr.27564 pubmed: 23303625 pmcid: 3517454
Lukesova L et al (2016) Prognostic influence of internal mammary node drainage in patients with early-stage breast cancer. Anticancer Res 36(12):6641–6646. https://doi.org/10.21873/anticanres.11272
doi: 10.21873/anticanres.11272 pubmed: 27919996

Auteurs

Josephine Situ (J)

Department of Engineering Science, The University of Auckland, Auckland, New Zealand.

Cameron Walker (C)

Department of Engineering Science, The University of Auckland, Auckland, New Zealand.

Tharanga D Jayathungage Don (TD)

Auckland Bioengineering Institute, The University of Auckland, Auckland, New Zealand.

Hiroo Suami (H)

Australian Lymphoedema Education Research and Treatment Program (ALERT), Department of Health Sciences, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, NSW, Australia.

David K V Chung (DKV)

Alfred Nuclear Medicine and Ultrasound, Newtown, NSW, Australia.
Discipline of Child and Adolescent Health, Sydney Medical School, University of Sydney, Sydney, NSW, Australia.

Hayley M Reynolds (HM)

Auckland Bioengineering Institute, The University of Auckland, Auckland, New Zealand. Hayley.Reynolds@auckland.ac.nz.

Classifications MeSH